331 related articles for article (PubMed ID: 16395496)
1. Residual kidney function after donor nephrectomy. Assessment by 99mTc-MAG3-clearance.
Hamscho N; Wilhelm A; Döbert N; Menzel C; Gossmann J; Berner U; Zaplatnikov K; Scheuermann EH; Grünwald F
Nuklearmedizin; 2005; 44(5):200-4. PubMed ID: 16395496
[TBL] [Abstract][Full Text] [Related]
2. Kidney function after nephrectomy for renal cell carcinoma.
Shirasaki Y; Tsushima T; Saika T; Nasu Y; Kumon H
Urology; 2004 Jul; 64(1):43-7; discussion 48. PubMed ID: 15245931
[TBL] [Abstract][Full Text] [Related]
3. Predicting postoperative renal insufficiency in patients undergoing nephrectomy for renal malignancy: assessment by renal scintigraphy using 99mtechnetium-mercaptoacetyltriglycine.
Shirasaki Y; Saika T; Tsushima T; Nasu Y; Arata R; Kumon H
J Urol; 2005 Feb; 173(2):388-90. PubMed ID: 15643177
[TBL] [Abstract][Full Text] [Related]
4. Comparison of camera-based 99mTc-MAG3 and 24-hour creatinine clearances for evaluation of kidney function.
Esteves FP; Halkar RK; Issa MM; Grant S; Taylor A
AJR Am J Roentgenol; 2006 Sep; 187(3):W316-9. PubMed ID: 16928911
[TBL] [Abstract][Full Text] [Related]
5. 99mTc-MAG3 renography: normal values for MAG3 clearance and curve parameters, excretory parameters, and residual urine volume.
Esteves FP; Taylor A; Manatunga A; Folks RD; Krishnan M; Garcia EV
AJR Am J Roentgenol; 2006 Dec; 187(6):W610-7. PubMed ID: 17114514
[TBL] [Abstract][Full Text] [Related]
6. Effects of radiofrequency ablation on individual renal function: assessment by technetium-99m mercaptoacetyltriglycine renal scintigraphy.
Mukai T; Sato S; Iguchi T; Mimura H; Yasui K; Gobara H; Saika T; Nasu Y; Kumon H; Kanazawa S
Acta Med Okayama; 2006 Apr; 60(2):85-91. PubMed ID: 16680184
[TBL] [Abstract][Full Text] [Related]
7. The assessment of residual kidney function after living donor nephrectomy.
Bieniasz M; Domagala P; Kwiatkowski A; Gozdowska J; Krzysztof O; Kieszek RA; Trzebicki J; Durlik M; Rowinski W; Chmura A
Transplant Proc; 2009; 41(1):91-2. PubMed ID: 19249485
[TBL] [Abstract][Full Text] [Related]
8. The assessment of renal cortex and parenchymal volume using automated CT volumetry for predicting renal function after donor nephrectomy.
Mitsui Y; Sadahira T; Araki M; Wada K; Tanimoto R; Ariyoshi Y; Kobayashi Y; Watanabe M; Watanabe T; Nasu Y
Clin Exp Nephrol; 2018 Apr; 22(2):453-458. PubMed ID: 28741049
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-mercaptoacetyltriglycine camera-based measurement of renal clearance: should the result be normalized for body surface area?
Klingensmith WC
J Nucl Med Technol; 2013 Dec; 41(4):279-82. PubMed ID: 24167023
[TBL] [Abstract][Full Text] [Related]
10. Determination of extrarenal plasma clearance and hepatic uptake of technetium-99m-mercaptoacetyltriglycine in cats.
Drost WT; McLoughlin MA; Mattoon JS; Lerche P; Samii VF; DiBartola SP; Chew DJ; Barthez PY
Am J Vet Res; 2003 Sep; 64(9):1076-80. PubMed ID: 13677382
[TBL] [Abstract][Full Text] [Related]
11. Effect of warm ischemia on renal function during partial nephrectomy: assessment with new 99mTc-mercaptoacetyltriglycine scintigraphy parameter.
Funahashi Y; Hattori R; Yamamoto T; Sassa N; Fujita T; Gotoh M
Urology; 2012 Jan; 79(1):160-4. PubMed ID: 22070892
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m mercaptoacetyltriglycine clearance values in children with minimal renal disease: can a normal range be determined?
Meyer G; Piepsz A; Kolinska J; Lepej J; Sixt R; Hahn K
Eur J Nucl Med; 1998 Jul; 25(7):760-5. PubMed ID: 9662599
[TBL] [Abstract][Full Text] [Related]
13. Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted?
Werner RA; Bluemel C; Lapa C; Muegge DO; Kudlich T; Buck AK; Herrmann K
Nucl Med Commun; 2014 Nov; 35(11):1143-9. PubMed ID: 25171439
[TBL] [Abstract][Full Text] [Related]
14. Risk of live kidney donation--Indian perspective.
Sahay M; Narayen G; Anuradha
J Assoc Physicians India; 2007 Apr; 55():267-70. PubMed ID: 17694785
[TBL] [Abstract][Full Text] [Related]
15. Prolonged renal parenchymal retention of 99mTc mercaptoacetyltriglycine after nephron-sparing surgery.
Inoue Y; Kurimoto S; Kameyama S; Ohta N; Akahane M; Yoshikawa K; Yokoyama I; Minami M; Ohtomo K; Kitamura T
Nucl Med Commun; 2004 May; 25(5):509-13. PubMed ID: 15100511
[TBL] [Abstract][Full Text] [Related]
16. Renal outcome 25 years after donor nephrectomy.
Goldfarb DA; Matin SF; Braun WE; Schreiber MJ; Mastroianni B; Papajcik D; Rolin HA; Flechner S; Goormastic M; Novick AC
J Urol; 2001 Dec; 166(6):2043-7. PubMed ID: 11696703
[TBL] [Abstract][Full Text] [Related]
17. Medical risk analysis of renal transplant donors.
Berber I; Tellioglu G; Kilicoglu G; Ozgezer T; Canbakan M; Gulle S; Yigit B; Titiz I
Transplant Proc; 2008; 40(1):117-9. PubMed ID: 18261562
[TBL] [Abstract][Full Text] [Related]
18. Technetium-99m labeled renal function and imaging agents: II. Clinical evaluation of 99mTc MAG3 (99mTc mercaptoacetylglycylglycylglycine).
Bubeck B; Brandau W; Steinbächer M; Reinbold F; Dreikorn K; Eisenhut M; Georgi P
Int J Rad Appl Instrum B; 1988; 15(1):109-18. PubMed ID: 2965116
[TBL] [Abstract][Full Text] [Related]
19. (99m)Tc-mercaptoacetyl triglycine renography to monitor renal transplant function among kidneys from donors after cardiac death.
Majima T; Hattori R; Funahashi Y; Komatsu T; Kato M; Yamada S; Kamihira O; Goto M
Transplant Proc; 2012 Jan; 44(1):49-53. PubMed ID: 22310576
[TBL] [Abstract][Full Text] [Related]
20. Computed Tomography Volumetry in Preoperative Living Kidney Donor Assessment for Prediction of Split Renal Function.
Wahba R; Franke M; Hellmich M; Kleinert R; Cingöz T; Schmidt MC; Stippel DL; Bangard C
Transplantation; 2016 Jun; 100(6):1270-7. PubMed ID: 26356175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
